Newsroom

Home / Newsroom / Positive Phase I Results from CAR-T CD30 Immuno-Oncology Clinical Development Program
22May

Positive Phase I Results from CAR-T CD30 Immuno-Oncology Clinical Development Program

Download Full Article as .PDF (Size: 157 kB)

This CBMG article was posted on 22 May 2015